LATEST ALERTS
Description
The Lithuanian legislation distinguishes between industrial hemp (grown for fibre hemp) and cannabis. The distinction between hemp and cannabis is made by the concentration of THC, which cannot exceed 0.3% in industrial hemp. Therefore, cannabis can be considered any plant which presents a THC concentration of above 0.3%.
This report provides a detailed overview of the current regulatory framework in place in Lithuania for hemp and cannabis, as well as CBD, IHDCs and medical and recreational cannabis, covering all policy areas.
Reasons to buy
This CannIntelligence regulatory report will provide you with:
- A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
- The ability to plan ahead for specific regulatory changes.
- Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
- Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.
Table of contents
- Executive summary
- Outlook
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Methodology
Our research is completely independent and original. It is conducted by CannIntelligence’s multilingual legal analysis team, all specialists in this sector, and goes through a rigorous review and editing process before publication. Research draws on multiple sources, including: online and offline resources and data, specialist legal software, our own extensive databases and report archives, interviews with key stakeholders and government officials, and collaboration with local legal firms and on-the-ground professionals in the jurisdictions covered.
Latest reports
